Search - tctmd.com

Displaying 561 - 580 of 908

Sort: Relevancy | Date

News Daily News

Higher Mortality Risks in Smokers With Coronary and Aortic Calcification

Michael O'Riordan

January 16, 2019

News Daily News

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Michael O'Riordan

January 15, 2019

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Michael O'Riordan

January 07, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Michael O'Riordan

October 18, 2018

Advertisement

Higher Mortality Risks in Smokers With Coronary and Aortic Calcification

Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Working Less, Earning Less: Stroke, MI, and Cardiac Arrest Have Long-term Labor Consequences

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Aspirin Should Play Limited Role in Primary Prevention: Review

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content